Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

BACKGROUND: In rats, amino acid mixtures lacking tyrosine and its precursor phenylalanine decrease the release of dopamine produced by the psychostimulant drug amphetamine. Amphetamine has been proposed as a model for clinical mania. AIMS: To assess whether dietary tyrosine depletion attenuates the...

Full description

Bibliographic Details
Main Authors:	McTavish, S, McPherson, M, Harmer, C, Clark, L, Sharp, T, Goodwin, G, Cowen, P
Format:	Journal article
Language:	English
Published:	2001

Similar Items

The effects of dietary tyrosine depletion by a branch chain amino acid mixture in acutely manic patients
by: Scarna, A, et al.
Published: (2002)

Attenuation of some subjective effects of amphetamine following tyrosine depletion.
by: McTavish, S, et al.
Published: (1999)

Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects.
by: Sheehan, B, et al.
Published: (1996)

Tyrosine depletion attenuates dopamine function in healthy volunteers.
by: Harmer, C, et al.
Published: (2001)

Tyrosine depletion in recovered depressed women
by: Mannie, Z, et al.
Published: (2004)

Lack of effect of tyrosine depletion on mood in recovered depressed women.
by: McTavish, S, et al.
Published: (2005)

Tyrosine depletion attenuates the behavioural stimulant effects of amphetamine and cocaine in rats.
by: McTavish, S, et al.
Published: (2001)

Effects of acute tyrosine depletion on subjective craving and selective processing of smoking-related cues in abstinent cigarette smokers.
by: Munafò, MR, et al.
Published: (2007)

Reduction of brain dopamine concentration with dietary tyrosine plus phenylalanine depletion: an [11C]raclopride PET study.
by: Montgomery, A, et al.
Published: (2003)

Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.
by: McTavish, S, et al.
Published: (2004)

Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release.
by: McTavish, S, et al.
Published: (1999)

Comparison of the effects of alpha-methyl-p-tyrosine and a tyrosine-free amino acid load on extracellular noradrenaline in the rat hippocampus in vivo.
by: McTavish, S, et al.
Published: (1999)

The measurement of transmembrane cation transport in vivo in acute manic illness.
by: Wood, A, et al.
Published: (1989)

Acute tryptophan depletion increases cingulate cortex reactivity in recovered depressed patients
by: Horder, J, et al.
Published: (2010)

EFFECTS OF ACUTE TRYPTOPHAN DEPLETION ON CINGULATE CORTEX REACTIVITY AND BRAIN CEREBRAL BLOOD FLOOD - AN MRI STUDY
by: Horder, J, et al.
Published: (2010)

Acute Tryptophan Depletion Increases Cingulate Cortex Reactivity in Recovered Depressed Patients - An fMRI Investigation
by: Horder, J, et al.
Published: (2010)

Low-dose tryptophan depletion in recovered depressed women induces impairments in autobiographical memory specificity.
by: Haddad, A, et al.
Published: (2009)

Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.
by: Pringle, A, et al.
Published: (2011)

Short-term NK1 receptor antagonism and emotional processing in healthy volunteers
by: Pringle, A, et al.
Published: (2010)

Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
by: Williamson, D, et al.
Published: (1995)

Short-term quetiapine treatment alters the use of reinforcement signals during risky decision-making and promotes the choice of negative expected values in healthy adult males.
by: Rock, P, et al.
Published: (2013)

Fos immunocytochemical studies on the neuroanatomical sites of action of acute tyrosine depletion in the rat brain.
by: Le Masurier, M, et al.
Published: (2004)

Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression.
by: Harmer, C, et al.
Published: (2002)

Repeated administration of citalopram or reboxetine reduces the perception of negative emotions from facial expression.
by: Harmer, C, et al.
Published: (2002)

A single dose of citalopram increases fear recognition in healthy subjects.
by: Browning, M, et al.
Published: (2007)

The effects of quetiapine on emotional processing
by: Rock, P, et al.
Published: (2011)

Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study.
by: Mocking, R, et al.
Published: (2013)

Repetitive transcranial magnetic stimulation to right prefrontal cortex does not modulate the psychostimulant effects of amphetamine.
by: Clark, L, et al.
Published: (2000)

Effects of a branched-chain amino acid drink in mania.
by: Scarna, A, et al.
Published: (2003)

Comparative efficacy of anti-manic drugs in acute mania Reply
by: Cipriani, A, et al.
Published: (2012)

Effect of acute tyrosine depletion in using a branched chain amino-acid mixture on dopamine neurotransmission in the rat brain.
by: Le Masurier, M, et al.
Published: (2006)

Effects of short-term varenicline administration on cortisol in healthy, non-smoking adults: a randomized, double-blind, study.
by: Mocking, R, et al.
Published: (2014)

Negative ion treatment increases positive emotional processing in seasonal affective disorder.
by: Harmer, C, et al.
Published: (2012)

THE EFFECTS OF QUETIAPINE ON RISKY DECISION-MAKING
by: Rock, P, et al.
Published: (2010)

The Effects of Quetiapine on Risky Decision-Making
by: Rock, P, et al.
Published: (2011)

Effect of valine on 5-HT neurotransmission and mood.
by: Cowen, P, et al.
Published: (1996)

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine.
by: Hajós-Korcsok, E, et al.
Published: (2000)

A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function.
by: Gijsman, H, et al.
Published: (2002)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.
by: Pringle, A, et al.
Published: (2012)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
by: Pringle, A, et al.
Published: (2012)